Gong, Xue
Yang, Min
Zhang, Zixin
Qiu, Tong
Zhou, Jiangyuan
Shan, Wei
Zhang, Xuepeng
Lan, Yuru
Bao, Pingqian
Zhou, Zilong
Yang, Congxia
Zhang, Yujia
Li, Tianliang
Guo, Jing
Guo, Jun
Lu, Guoyan
Kong, Feiteng
Zhang, Yongbo
Chen, Siyuan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
https://doi.org/10.1007/s12072-024-10756-5
Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size
https://doi.org/10.1007/s13555-022-00756-4
Funding for this research was provided by:
National Natural Science Foundation of China (82273556, 82473553)
Key Project in the Science & Technology Program of Sichuan Province (2022YFS0233, 2022YFS0225)
Project of ‘0 to 1’ of Sichuan University (2022SCUH0033)
1·3·5 Project for Disciplines of Excellence-Clinical Research Interdisciplinary Innovation Project of West China Hospital of Sichuan University (ZYJC21060)
1·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University (2023HXFH004, 2019HXFH056, 2020HXFH048)
Med-X Center for Informatics Funding Project (YGJC004)
Article History
Received: 23 August 2024
Accepted: 9 November 2024
First Online: 29 November 2024
Declarations
:
: Xue Gong, Min Yang, Zixin Zhang, Tong Qiu, Jiangyuan Zhou, Wei Shan, Xuepeng Zhang, Yuru Lan, Pingqian Bao, Zilong Zhou, Congxia Yang, Yujia Zhang, Tianliang Li, Jing Guo, Jun Guo, Guoyan Lu, Feiteng Kong, Yongbo Zhang, Siyuan Chen and Yi Ji declare that they have no conflict of interest.
: This study was approved by the ethics committee on medical research of each participating site. Written informed consent was not needed from the patients’ parents or legal guardians because of the retrospective design of this study and the anonymous collection of analytical data.